Home › Funds › Darsana Capital Partners LP › HCA
Darsana Capital Partners LP position in HCA
HCA Healthcare Inc · Health Care
Darsana Capital Partners LP reported holding 1,100,000 shares of HCA (HCA Healthcare Inc) in its Q2 2026 13F filing — a position valued at US$428.9M, representing 1.93% of its reported portfolio and ranking #6 among its reported holdings. Darsana Capital Partners LP has disclosed HCA holdings in 10 of the last 10 reported quarters, going back to Q1 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Darsana Capital Partners LP's HCA position evolved
Darsana Capital Partners LP first disclosed a stake in HCA in Q1 2024 at 750,000 shares (US$250.1M). The position peaked in Q3 2024 at 1,150,000 shares, worth US$467.4M. Across 10 filings, Darsana Capital Partners LP increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 1,100,000 shares valued at US$428.9M — an increase of 350,000 shares quarter over quarter.. Notable position changes include a 53% increase in Q2 2024 (shares rose 26% over the following quarter), a 25% trim in Q1 2026 (shares fell 18% over the following quarter), a 47% increase in Q2 2026 (shares rose 9% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 750.00K | $250.15M | New |
| Q2 2024 | 1.15M | $369.47M | Add |
| Q3 2024 | 1.15M | $467.39M | Hold |
| Q4 2024 | 1.23M | $367.68M | Add |
| Q1 2025 | 1.25M | $431.94M | Add |
| Q2 2025 | 1.00M | $383.10M | Reduce |
| Q3 2025 | 1.00M | $426.20M | Hold |
| Q4 2025 | 1.00M | $466.86M | Hold |
| Q1 2026 | 750.00K | $354.93M | Reduce |
| Q2 2026 | 1.10M | $428.88M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About HCA and 13F data
HCA (HCA Healthcare Inc) is a Health Care company. 24 other funds we track also report a position in HCA — the largest reported positions include Sanders Capital, LLC (US$3.44B), First Eagle Investment Management (US$1.28B), Arrowstreet Capital (US$861.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding HCA
- Sanders Capital, LLC 8.83M sh · $3.44B · Q2 2026
- First Eagle Investment Management 3.30M sh · $1.28B · Q2 2026
- Arrowstreet Capital 2.21M sh · $861.46M · Q2 2026
- NORDEA INVESTMENT MANAGEMENT AB 1.43M sh · $553.70M · Q2 2026
- Crake Asset Management LLP 1.15M sh · $449.07M · Q2 2026
More on Darsana Capital Partners LP
FAQ
How long has Darsana Capital Partners LP held HCA?
Darsana Capital Partners LP has disclosed HCA holdings in 10 of the last 10 reported quarters, going back to Q1 2024.
What is Darsana Capital Partners LP's current position in HCA?
As of Q2 2026, Darsana Capital Partners LP holds 1.10M shares of HCA (HCA Healthcare Inc), valued at $428.88M, representing 1.93% of its reported portfolio and ranking #6.
Has Darsana Capital Partners LP been buying or selling HCA?
In the latest 13F filing (Q2 2026), Darsana Capital Partners LP increased its position in HCA. The position peaked in Q3 2024 at 1.15M shares.
Which other funds hold HCA?
Other major institutional holders of HCA include Sanders Capital, LLC, First Eagle Investment Management, Arrowstreet Capital, among 24 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.